Literature DB >> 15968069

Host- and tissue-specific pathogenic traits of Staphylococcus aureus.

Willem B van Leeuwen1, Damian C Melles, Alwaleed Alaidan, Mohammed Al-Ahdal, Hélène A M Boelens, Susan V Snijders, Heiman Wertheim, Engeline van Duijkeren, Justine K Peeters, Peter J van der Spek, Roy Gorkink, Guus Simons, Henri A Verbrugh, Alex van Belkum.   

Abstract

Comparative genomics were used to assess genetic differences between Staphylococcus aureus strains derived from infected animals versus colonized or infected humans. A total of 77 veterinary isolates were genetically characterized by high-throughput amplified fragment length polymorphism (AFLP). Bacterial genotypes were introduced in a large AFLP database containing similar information for 1,056 human S. aureus strains. All S. aureus strains isolated from animals in close contact with humans (e.g., pet animals) were predominantly classified in one of the five main clusters of the AFLP database (cluster I). In essence, mastitis-associated strains from animals were categorized separately (cluster IVa) and cosegregated with bacteremia-associated strains from humans. Distribution of only 2 out of 10 different virulence genes differed across the clusters. The gene encoding the toxic shock syndrome protein (tst) was more often encountered among veterinary strains (P < 0.0001) and even more in the mastitis-related strains (P<0.0001) compared to human isolate results. The gene encoding the collagen binding protein (cna) was rarely detected among invasive human strains. The virulence potential, as indicated by the number of virulence genes per strain, did not differ significantly between the human- and animal-related strains. Our data show that invasive infections in pets and humans are usually due to S. aureus strains with the same genetic background. Mastitis-associated S. aureus isolated in diverse farm animal species form a distinct genetic cluster, characterized by an overrepresentation of the toxic shock syndrome toxin superantigen-encoding gene.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15968069      PMCID: PMC1151784          DOI: 10.1128/JB.187.13.4584-4591.2005

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  44 in total

1.  Nucleotide sequence of the gene for a fibronectin-binding protein from Staphylococcus aureus: use of this peptide sequence in the synthesis of biologically active peptides.

Authors:  C Signäs; G Raucci; K Jönsson; P E Lindgren; G M Anantharamaiah; M Höök; M Lindberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  Cross-infection between animals and man: possible feline transmission of Staphylococcus aureus infection in humans?

Authors:  G M Scott; R Thomson; J Malone-Lee; G L Ridgway
Journal:  J Hosp Infect       Date:  1988-07       Impact factor: 3.926

3.  Production of enterotoxins and toxic shock syndrome toxin by bovine mammary isolates of Staphylococcus aureus.

Authors:  K Kenny; R F Reiser; F D Bastida-Corcuera; N L Norcross
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

Review 4.  Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses.

Authors:  G A Bohach; D J Fast; R D Nelson; P M Schlievert
Journal:  Crit Rev Microbiol       Date:  1990       Impact factor: 7.624

5.  Drosophila melanogaster as a model host for Staphylococcus aureus infection.

Authors:  Andrew J Needham; Monica Kibart; Howard Crossley; Philip W Ingham; Simon J Foster
Journal:  Microbiology (Reading)       Date:  2004-07       Impact factor: 2.777

6.  Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus.

Authors:  D McDevitt; P Francois; P Vaudaux; T J Foster
Journal:  Mol Microbiol       Date:  1994-01       Impact factor: 3.501

7.  Prevalence of staphylococcal zoonosis in pyogenic skin infections.

Authors:  P N Rao; A S Naidu; P R Rao; K Rajyalakshmi
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1987-06

8.  Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study.

Authors:  Heiman F L Wertheim; Margreet C Vos; Alewijn Ott; Andreas Voss; Jan A J W Kluytmans; Christina M J E Vandenbroucke-Grauls; Marlene H M Meester; Peter H J van Keulen; Henri A Verbrugh
Journal:  Ann Intern Med       Date:  2004-03-16       Impact factor: 25.391

9.  Molecular characterization and expression of a gene encoding a Staphylococcus aureus collagen adhesin.

Authors:  J M Patti; H Jonsson; B Guss; L M Switalski; K Wiberg; M Lindberg; M Höök
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

10.  Characteristics of Staphylococcus aureus isolated from lesions of horses.

Authors:  A Shimizu; J Kawano; J Ozaki; N Sasaki; S Kimura; M Kamada; S Anzai; H Saito; H Sato
Journal:  J Vet Med Sci       Date:  1991-08       Impact factor: 1.267

View more
  34 in total

1.  Regional profiling for determination of genotype diversity of mastitis-specific Staphylococcus aureus lineage in Canada by use of clumping factor A, pulsed-field gel electrophoresis, and spa typing.

Authors:  Kamaleldin B Said; Johanne Ismail; Jennifer Campbell; Michael R Mulvey; Anne-Marie Bourgault; Serge Messier; Xin Zhao
Journal:  J Clin Microbiol       Date:  2009-12-02       Impact factor: 5.948

Review 2.  Mastitis: comparative etiology and epidemiology.

Authors:  G Andres Contreras; Juan Miguel Rodríguez
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-09-27       Impact factor: 2.673

3.  Differential abilities of capsulated and noncapsulated Staphylococcus aureus isolates from diverse agr groups to invade mammary epithelial cells.

Authors:  Fernanda R Buzzola; Lucía P Alvarez; Lorena P N Tuchscherr; María S Barbagelata; Santiago M Lattar; Luis Calvinho; Daniel O Sordelli
Journal:  Infect Immun       Date:  2006-12-04       Impact factor: 3.441

4.  Molecular analysis of human and canine Staphylococcus aureus strains reveals distinct extended-host-spectrum genotypes independent of their methicillin resistance.

Authors:  S Vincze; I Stamm; S Monecke; P A Kopp; T Semmler; L H Wieler; A Lübke-Becker; B Walther
Journal:  Appl Environ Microbiol       Date:  2012-11-16       Impact factor: 4.792

5.  Screening of Staphylococcus aureus nasal strains isolated from medical students for toxin genes.

Authors:  L Piechowicz; K Garbacz; K Wiśniewska; M Dąbrowska-Szponar
Journal:  Folia Microbiol (Praha)       Date:  2011-05-31       Impact factor: 2.099

6.  Genome-wide analysis of ruminant Staphylococcus aureus reveals diversification of the core genome.

Authors:  Nouri L Ben Zakour; Daniel E Sturdevant; Sergine Even; Caitriona M Guinane; Corinne Barbey; Priscila D Alves; Marie-Françoise Cochet; Michel Gautier; Michael Otto; J Ross Fitzgerald; Yves Le Loir
Journal:  J Bacteriol       Date:  2008-06-20       Impact factor: 3.490

7.  Heterogeneity of the humoral immune response following Staphylococcus aureus bacteremia.

Authors:  N J Verkaik; H A Boelens; C P de Vogel; M Tavakol; L G M Bode; H A Verbrugh; A van Belkum; W J B van Wamel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-02-26       Impact factor: 3.267

8.  Molecular types and genetic profiles of Staphylococcus aureus strains isolated from bovine intramammary infections and extramammary sites.

Authors:  M Haveri; M Hovinen; A Roslöf; S Pyörälä
Journal:  J Clin Microbiol       Date:  2008-09-17       Impact factor: 5.948

9.  Distribution of the serine-aspartate repeat protein-encoding sdr genes among nasal-carriage and invasive Staphylococcus aureus strains.

Authors:  Artur Sabat; Damian C Melles; Gayane Martirosian; Hajo Grundmann; Alex van Belkum; Waleria Hryniewicz
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

10.  MRSA transmission between cows and humans.

Authors:  Eva Juhász-Kaszanyitzky; Szilárd Jánosi; Pál Somogyi; Adám Dán; Linda van der Graaf-van Bloois; Engeline van Duijkeren; Jaap A Wagenaar
Journal:  Emerg Infect Dis       Date:  2007-04       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.